TY - JOUR
T1 - Smith–Magenis syndrome: Report of morphological and new functional cardiac findings with review of the literature
AU - Onesimo, Roberta
AU - Versacci, Paolo
AU - Delogu, Angelica Bibiana
AU - De Rosa, Gabriella
AU - Pugnaloni, Flaminia
AU - Blandino, Rita
AU - Leoni, Chiara
AU - Calcagni, Giulio
AU - Digilio, Maria C.
AU - Zollino, Marcella
AU - Marino, Bruno
AU - Zampino, Giuseppe
PY - 2021
Y1 - 2021
N2 - Smith–Magenis syndrome (SMS) is a genetic disorder characterized by multiple congenital anomalies, sleep disturbance, behavioral impairment, and intellectual disability. Its genetic cause has been defined as an alteration in the Retinoic Acid-Induced 1 gene. Cardiac anomalies have been reported since the first description of this condition in patients with 17p11.2 deletion. Variable cardiac defects, including ventricular septal defects, atrial septal defects, tricuspid stenosis, mitral stenosis, tricuspid and mitral regurgitation, aortic stenosis, pulmonary stenosis, mitral valve prolapse, tetralogy of Fallot, and total anomalous pulmonary venous connection, have been anecdotally reported and systematic case series are still lacking. Herein, we define the spectrum of the cardiac phenotype and describe for the first time the cardiac function in a large cohort of pediatric patients with SMS. Revision of the literature and correlations between genotype and cardiac phenotype was performed.
AB - Smith–Magenis syndrome (SMS) is a genetic disorder characterized by multiple congenital anomalies, sleep disturbance, behavioral impairment, and intellectual disability. Its genetic cause has been defined as an alteration in the Retinoic Acid-Induced 1 gene. Cardiac anomalies have been reported since the first description of this condition in patients with 17p11.2 deletion. Variable cardiac defects, including ventricular septal defects, atrial septal defects, tricuspid stenosis, mitral stenosis, tricuspid and mitral regurgitation, aortic stenosis, pulmonary stenosis, mitral valve prolapse, tetralogy of Fallot, and total anomalous pulmonary venous connection, have been anecdotally reported and systematic case series are still lacking. Herein, we define the spectrum of the cardiac phenotype and describe for the first time the cardiac function in a large cohort of pediatric patients with SMS. Revision of the literature and correlations between genotype and cardiac phenotype was performed.
KW - Smith–Magenis syndrome
KW - congenital heart disease
KW - functional cardiac findings
KW - personalized medicine
KW - phenotype–genotype correlation
KW - Smith–Magenis syndrome
KW - congenital heart disease
KW - functional cardiac findings
KW - personalized medicine
KW - phenotype–genotype correlation
UR - http://hdl.handle.net/10807/179361
U2 - 10.1002/ajmg.a.62196
DO - 10.1002/ajmg.a.62196
M3 - Article
SN - 1552-4825
SP - N/A-N/A
JO - AMERICAN JOURNAL OF MEDICAL GENETICS. PART A
JF - AMERICAN JOURNAL OF MEDICAL GENETICS. PART A
ER -